Enhanced prediction of fracture risk combining vertebral fracture status and BMD

[1] Cummings SR(2002)Epidemiology and outcomes of osteoporotic fractures Lancet 359 1761-1767

[2] Melton LJI(1999)Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators JAMA 282 637-645

[3] Ettinger B(1996)Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group Lancet 348 1535-1541

[4] Black DM(1998)Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial JAMA 280 2077-2082

[5] Mitlak BH(1999)Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group J Bone Miner Res 14 821-828

[6] Black DM(2001)Risk of new vertebral fracture in the year following a fracture JAMA 285 320-323

[7] Cummings SR(1999)Pre-existing fractures and bone mass predict vertebral fracture incidence in women Ann Intern Med 114 919-923

[8] Karpf DB(2005)Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures J Clin Endocrinol Metab 90 1583-1587

[9] Cummings SR(2003)Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial Bone 33 522-532

[10] Black DM(2000)Vertebral fractures in osteoporosis: a new method for clinical assessment J Clin Densitom 3 281-290

[1] Cummings SR(2002)Epidemiology and outcomes of osteoporotic fractures Lancet 359 1761-1767

[2] Melton LJI(1999)Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators JAMA 282 637-645

[3] Ettinger B(1996)Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group Lancet 348 1535-1541

[4] Black DM(1998)Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial JAMA 280 2077-2082

[5] Mitlak BH(1999)Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group J Bone Miner Res 14 821-828

[6] Black DM(2001)Risk of new vertebral fracture in the year following a fracture JAMA 285 320-323

[7] Cummings SR(1999)Pre-existing fractures and bone mass predict vertebral fracture incidence in women Ann Intern Med 114 919-923

[8] Karpf DB(2005)Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures J Clin Endocrinol Metab 90 1583-1587

[9] Cummings SR(2003)Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial Bone 33 522-532

[10] Black DM(2000)Vertebral fractures in osteoporosis: a new method for clinical assessment J Clin Densitom 3 281-290